Researchers examined the prevalence of depression symptoms compared to clinically diagnosed depression, as well as the association of depression with mortality in patients with rheumatoid arthritis.
Researchers explored the occurrence of sleep disturbances, fatigue, and anxiety/depression in patients with psoriatic arthritis.
Depression and anxiety are common in patients with rheumatoid arthritis.
The prevalence of mental distress is 16.8 percent and the prevalence of depression is 32.1 percent among adults with arthritis.
Patients with coexisting rheumatoid arthritis (RA) and depression tend to have higher disease activity and lower quality of life than patients without depression.
In recent years, researchers have investigated a potential link between gout and depression. We review clinical evidence on the subject.
Researchers assessed the effect of golimumab (TNFα blocker) and ustekinumab (IL-12/23 blocker) in improving depressive symptoms in patients with psoriatic arthritis.
Findings showed somewhat higher rates of treated depression among patients with psoriatic arthritis exposed to corticosteroids alone or in combination with any other study drug and among patients exposed to interleukin inhibitors alone or in combination with DMARDs.
Researchers aimed to identify factors related to depressive symptoms in ankylosing spondylitis and comprehend their underlying associations.
This study aimed to provide an estimate of depression prevalence among patients with ankylosing spondylitis vs those without ankylosing spondylitis.
